2024-05-02 16:00:15 ET
Bruker Corporation (BRKR)
Q1 2024 Earnings Call Transcript
May 02, 2024, 08:30 AM ET
Company Participants
Justin Ward - Senior Director of IR and Corporate Development
Frank Laukien - President and CEO
Gerald Herman - EVP and CFO
Conference Call Participants
Puneet Souda - Leerink Partners
Patrick Donnelly - Citi
Rachel Vatnsdal - JPMorgan
Jack Meehan - Nephron Research
Dan Brennan - TD Cowen
Dan Arias - Stifel
Josh Waldman - Cleveland Research
Presentation
Operator
Good morning and welcome to the Bruker Corporation First Quarter 2024 earnings conference call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please also note, today's event is being recorded. I'd now like to turn the floor over to Justin Ward, Senior Director on Investor Relations and Corporate Development. Please go ahead.
Justin Ward
Thank you, and good morning, everybody. I would like to welcome everyone to Bruker Corporation's first quarter 2024 earnings conference call. My name is Justin Ward, and I am Bruker's Senior Director of Investor Relations and Corporate Development. Joining me on today's call are Frank Laukien, our President and CEO, and Gerald Herman, our Executive Vice President and CFO. In addition to the earnings release we issued earlier today, during today's conference call, we will be referencing a slide presentation that can be downloaded from the events and presentation section of Bruker's investor relations website.
During today's call, we will be highlighting non-GAAP financial information. Reconciliation of our non-GAAP to GAAP financial measures are included in our earnings release and are posted on our website at ir.bruker.com. Before we begin, I would like to reference Bruker's safe harbor statement, which is shown on Slide 2 of the presentation. During this conference call, we will be making forward-looking statements regarding future events and the financial and operational performance of the company that involve risks and uncertainties, including those related to our recent and pending acquisitions, geopolitical risks and wars as well as supply chain, logistics and inflation. The company's actual results may differ materially from such statements. Factors that might cause such differences include, but are not limited to, those discussed in today's earnings release and in our Form 10-K for the period ending December 31, 2023, as updated by other SEC filings, which are available on our website and on the SEC websites. Also, please note that the following information is based on current business conditions and to our outlook as of today, May 2nd, 2024. You should not rely on these forward-looking statements as necessarily representing our views or outlooks as of any date after today.
We will begin today's call with Frank providing an overview of our business progress. Gerald will then cover the financials for the first quarter of 2024 in more detail and share our updated 2024 financial outlook....
Read the full article on Seeking Alpha
For further details see:
Bruker Corporation (BRKR) Q1 2024 Earnings Call Transcript